Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 1/2016

01.01.2016 | Erratum

Erratum to: Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study

verfasst von: Savvas Frangos, Ioannis P. Iakovou, Robert J. Marlowe, Nicolaos Eftychiou, Loukia Patsali, Anna Vanezi, Androulla Savva, Vassilis Mpalaris, Evanthia I. Giannoula

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Erratum to: European Journal of Nuclear Medicine and Molecular Imaging
Metadaten
Titel
Erratum to: Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study
verfasst von
Savvas Frangos
Ioannis P. Iakovou
Robert J. Marlowe
Nicolaos Eftychiou
Loukia Patsali
Anna Vanezi
Androulla Savva
Vassilis Mpalaris
Evanthia I. Giannoula
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2016
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-015-3238-8

Weitere Artikel der Ausgabe 1/2016

European Journal of Nuclear Medicine and Molecular Imaging 1/2016 Zur Ausgabe